Loading...

Cardiovascular Systems, Inc.

CSIINASDAQ
Healthcare
Medical - Devices
$20.00
$0.03(0.15%)

Cardiovascular Systems, Inc. (CSII) Company Profile & Overview

Explore Cardiovascular Systems, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Cardiovascular Systems, Inc. (CSII) Company Profile & Overview

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.

SectorHealthcare
IndustryMedical - Devices
CEOScott Raymond Ward MS

Contact Information

651 259 1600
1225 Old Highway 8 Northwest, Saint Paul, MN, 55112-6416

Company Facts

725 Employees
IPO DateJun 28, 2006
CountryUS

Frequently Asked Questions

;